3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra

The award forms part of an agreement between 3P and the Faculty of Pharmacy at the University of Navarra promoting digital transformation and professional training within the pharmaceutical industry.

 3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the best Final Project Degree (FPD) of Pharmacy.

The award forms part of an agreement between 3P and the Faculty of Pharmacy at the University of Navarra promoting digital transformation and professional training within the pharmaceutical industry. At the same time, encouraging research in technologies, and the production of new medicines, particularly in biotechnologies.

3P Biopharmaceuticals awards its first prize for the best Final Degree Project in Pharmacy at the University of Navarra

The first winner of the 3P award is Ángela Covo, a Pharmacy degree student, for her experimental work on: “Overcoming T cell dysfunction in the acidic tumor microenvironment.” Ángela successfully achieved a grade of 9.32 and was awarded a prize of €300 and a diploma.

According to the CEO of 3P Biopharmaceuticals, Dámaso Molero, “It is an honor to be able to present the first 3P Biopharmaceuticals Award for the best Final Degree Project. All the graduating students have obtained very high grades and it tells us that we are training future professionals with a technical-scientific profile of the highest level who will add a lot of value to Navarra and the Spanish biopharmaceutical sector.

The agreement with 3P and the Pharmacy Faculty concentrates on new medicine and advanced therapies in R&D, including the development of biological drugs, cell and gene therapy, manufacturing and analytical technology, and dispensing technology. With the intention of manufacturing drugs that are safer and aimed at diseases that, until now, have no cure or with treatments without serious side effects.

In addition to the 3P Final Degree Project award, the collaboration between the two bodies delivers events, courses, seminars, and scientific meetings.

View the full press release here

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1

Published: 15th November 2022
3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis.
Read more

3P Biopharmaceuticals awards the prize for the best Master’s Thesis (TFM)

Published: 3rd October 2022
At the closing of the fifth edition of the Master in Galenic Design and Manufacturing in the Pharmaceutical Industry of the University of Navarra.
Read more

3P Biopharmaceuticals among the 100 best companies to work for in Spain

Published: 27th September 2022
The prestigious ranking is based on an exhaustive questionnaire that Actualidad Económica prepares and publishes every year, and which seeks to evaluate and reward those companies whose human resources management makes them benchmarks.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.